版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
GettingBloodPressuretoGoalRulesofThree:3drugs3months3behaviors(Activity-Diet-ControlofTobaccoandAlcohol)3Partners(Patient–Family–Provider)ThisprogramwassponsoredbytheNationalKidneyFoundationofMichigan(NKFM)andtheMichiganDepartmentofCommunityHealth(MDCH).FundingwasprovidedbyagenerousgrantfromNKFMandMDCHandvariouspharmacompanies.ContinuingMedicalEducationcreditisprovidedbyWayneStateUniversitySchoolofMedicineTheprogramwasdevelopedandpreparedby:
DianeLevine,MDWayneStateUniversitySilasNorman,MD,UniversityofMichiganRosalindPeters,PhD,RN,WayneStateUniversitySusanSteigerwalt,MD,St.JohnHospitalWithinputfromtheHypertensionExpertGroupofNKFMandtheexpertiseandcreativityofitsmemberswithspecialthankstoVelmaTheisenandLindaSmithWheelockACSW,MSBAConflictofInterestIndividualSpeakerstoAddtheirinformationpriortopresenting
MajorityofUSHypertensivePatientsNotatSBPGoalof<140mmHgUnacceptableBPControlRatesRequireIncreasedAwareness,MoreAggressiveTreatmentSignificanceofHBPProblem50%ofhypertensivesareuncontrolled.UptohalfarenotreceivingpharmacologictreatmentAntihypertensivetherapycanStroke–30%CHF–40-50%CAD–10-20%CADEvents-~55%Mortality–10%~$1Billionindirectmedicalcosts/yearCardiovascularMortalityRiskDoublesWithEach20/10mmHgBPIncrement*CV-RelatedMortalityRatesAreHigherinAfricanAmericansCardiovascularEventsinTreatedHypertensiveDiabeticPatientsPreventingKidneyFailureAfricanAmericansinMichiganhavepoorerbloodpressurecontrolthanCaucasiansAfricanAmericansareatfivetimesgreaterriskofprogressiontoendstagerenaldiseaseBetterbloodpressurecontrolSLOWSPROGRESSIONofrenaldiseaseBPcontrolreducestheriskofstroke,MI,andCHFFactorsContributingtoPoorBPControlPatientFactorsAgeRace/ethnicityObesityAccessNonadherenceKnowledgeCostComplextreatmentPt/ProviderCommunicationSecondaryHTNProviderFactorsMeasurementissuesLackofknowledge/DisagreementwithguidelinesConcernforsideeffectsNon-advancingofdrugsinasymptomaticpatientsResponsetopatientsconcernsovercomplexityoftreatmentLackoftimeMeasurementAccuracyAccuracyofofficemeasurementsManual–RegularlycalibratedWhite-CoatSyndromeHomeMonitoring
OmronHealthcareArm(notwrist)monitorGoalreadings<135/85
MeasurementAccuracy*
PatientPosition:BacksupportedFeetonthefloorArmattheleveloftheheartNotalkingCuffSize–Mostadultsneedalargecuff(SeeCDandAHAwebsitefordetails)TaketwiceCheckorthostaticbloodpressure*CDprovidedtosupportreviewandstandardizationofBPmeasurementMeasurementAccuracy:
OrthostaticHypotension20%prevalenceincommunitydwellingadultsoverage65IncreaseswithagePresentinyoungerpatientswithdiabetesorautonomicdysfunction“Iforthostasiscannotbecorrected,usestandingBPtoassessgoalBP”(JNC-7)JNC7:NewBPClassificationsJNC7RecommendedBPGoals<140and<90mmHg
Patientswithmostconditions<130and<80mmHgDiabetesMellitusCKDAlbuminuria>300mg/24hror>200mg/gurinarycreatinineeGFR<60ml/min/1.73m2SerumcreatininelevelsaloneoverestimatekidneyfunctionAssessandaddressothercardiovascularriskfactorsChobanianAVetal.JAMA.2003;289:2560-2572.JNC7:ManagementofHypertensionbyBPClassificationCommonProviderConcernswithGuidelineGoals
NonAcceptanceofBPgoalsResistancetoacceptSBPthresholdsNottreatingunlessSBP>160mmHgConcernsofincreasedcardiovascularriskwithexcessiveloweringofDBP(J-Curve)BelievethatmoretimeisneededtoreachgoalVALUE,
LANCET,2004:363:2022-2031Ruleof3
“MDBP”3
Months3
Drugs3
Behaviors
(activity-diet-alcoholandtobaccocontrol)3
Partners
(Patient–Family–Provider)
ItMightTake3MonthsGettingBPtogoalin3monthsRequiresmultiplevisitsGettingtoGoalvisitschedule:MonthlyuntilgoalisreachedIncreasevisitfrequencyifStage2Increasevisitfrequencywithcomorbidconditions
Atgoal–followupvisitscheduleEvery3-6monthsdependingoncomorbiditiesCheckK+andCreatinine1-2x/year
DrugTherapyStepApproach:StartwithdiureticifnocontraindicationsAddACEICalciumChannelBlocker(CCB)Betablockers–butcautionMostpatientsrequire
multipledrugstoachievecontrol(average=3.5drugs)Usemultipledrugsif:BP20/10mmHgabovegoal(Stage22drugs)StandingBPabovegoalinpatientsoverage65orDMNotatgoalafter3monthsMultipleAntihypertensiveAgentsAreNeededtoAchieveTargetBloodPressureDrugTreatment:DiureticsIfnocompellingindications(CHF,diabetes,CKD)Chlorthalidone(orotherthiazides)firstThenACEIorARBRememberBetaBlockersARENOTforprimarypreventionandareinferiortodiureticsasmonotherapyVigilantlypreventhypokalemiaSpironolactone/HCTZisagreatcombination!BringpatientsbackinoneweektocheckfordiureticinducedhypokalemiaWatchforhyponatremiaDrugTreatment:ACEinhibitorsCheckElectrolytes,BUN,andCreatininepriortostartingRecheckK+andCreatinine1weekafterinitiationoftherapyGenericavailableBIDDosing:enalapril(5mgbid-20mgbid)captopril(12.5mgbid-50mgbid)DailyDosinglisinopril(5-40mgdaily)Sideeffects:Cough-switchtoARBifaffordableHyperkalemiaandacuterenalfailureAngioedemaWhatHaveWeLearned?
TreatmentTreatmentoftheveryelderlydecreases strokeandCADbutdoesnotprolongsurvival(Lancet1999:353:793)Bestdrugsinrankorder:ChlorthalidoneACEinhibitorHCTZ(Hypertension2004;44:800)CCB
WhatHaveWeLearned?
TreatmentACEIandARBdecreasenewonsetofdiabetesby25%comparedtobetablockers(LIFE);23%comparedtoCCBs(VALUEtrial)NewonsetofdiabeteswhileundergoingtreatmentforhypertensionconfersthesameexcessCVriskaspreexistingdiabetes(Hypertension(2004)43p.963)WhatHaveWeLearned?
TreatmentMonotherapywithatenololisNOTasefficaciousasotherantihypertensivesfordecreasingCVriskdespiteequivalentBPcontrol(Lancet:2004:364:1684)BetablockersareinferiortodiureticsforbloodpressurecontrolandCVriskprotection(stroke,CHF)inolderpatients(MRCtrial,1990;JAMA
1998;279:1903-1907;INVEST:JAMA290:2805-2816;ASCOTTrial)CombinationTreatmentsLogical/additivecombinationsDiuretic+ACEIorARBDiuretic+BetaBlockerorsympatholyticsCCB+ACEIorARBDiuretic+BetaBlocker+vasodilatorDiuretic+CCBCombinationTreatmentsCombinationswithNOadditiveeffectBetaBlocker+ACEIVasodilators+CCBCombinationwithadditivesideeffectsBetaBlocker+clonidineorguanfacineBetaBlocker+verapamilordiltiazemClonidine/guanfacine+verapamilordiltiazemWhenadding
Indifficulttocontrolpatients
ItTakes3DRUGS!ChoosealogicalADDITIVEcombinations:Diuretic+ACEI+CCBDiuretic+BBlocker+vasodilatorDiuretic+clonidine+vasodilatorSpecialPopulationsDiabetesACEIorARBDiureticsareimportantadjuncttherapyBScontrolassociatedwithBPcontrolCKDACEIorARBareimportanttopreserverenalfunctionIfeGFR<50starttorsemideorfurosemidebidPostMIBetablockersACEIorARBCheckK+andCreatininepriortoinitiatingand1weekafterinitiatingACE
ItMightTake3MonthsButifnotatgoalby6monthsconsider:PatientreasonsfornonadherenceSleepApneaAlcoholoveruseDiabetesChronicKidneyDiseaseSecondarycausesConsultwithorrefertoHypertensionSpecialist
VALUE,LANCET,2004:363:2022-2031SleepApneaUpto60%maleswithresistanthypertension(alsocommoninpostmenopausalfemales)Suspectdiagnosis-screenandreferPathophysiologyofhypertensionlikelySNSactivation
Lifestyle:ItTakes3BEHAVIORSExerciseDietControloftobaccoandalcoholLifestyle:Exercise4-9mmHgSBPreduction30-45minutes/day/5-7days/weekAerobicactivity(e.g.briskwalking)WriteaprescriptionFavoritePatientSig40minutesofwalking5X/wk BPMD3333Lifestyle:DietWeightControl
5-20mmHgSBPreduction/10kgLowSodium(<2.4g)
2-8mmHgSBPreductionDASH8-14mmHgSBPreductionControlofTobaccoandAlcoholSmokingCessationWriteprescriptionAlcoholModeration<2alcoholicdrinks/day–men<1alcoholicdrink/day–women2-4mmHgreductioninSBPAccessforothersubstancesPartners:Ittakes3PartnersPatientFamilyProviderProvider/PatientRelationshipKeyThePatient:Participationiscrucial
Describethejourney“Thisisaseriousdisease”“Iwillneedtoseeyouevery4-6weeks”“Thisisyourgoal<140/90(or130/80)”“Achievingyourgoalisimportantbecauseitlowersyourriskof…Sharegoalsetting“Let’ssetsomegoals“Thishowcanyouhelp“Whatareyouwillingtodo?“Weareateam—Patient,provider,“family”Ifwedonotachieveyourgoals…Partners:PatientsPatientnon-adherencetotherapyLackofconcernifasymptomaticFeel“better”withhigherBPDon’tworryabout“touch”ofhighBPMistrustofhealthcareprovidersandhealthcaresystemImprovedadherencewithIncreasedcontactwithprovidersSelf/homeBPmeasurement-OMRONarm,usuallyLARGEADULTcuff(Bladderencircling80%arm)Useofpatientrecordtokeeptrackofinfluenceoffactors(e.g.diet)onBPPartners:
“Family”,Friends,CommunityInvolve“family”wheneverpossibleEssentialforlifestylemodificationBefamiliarwithcommunityresourcesPartners:ProvidersFollowJNCandMQIC*GuidelinesDocumentGoalSchedulefrequentv
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024年临床执业医师外科学真题及答案
- (2025年)客运从业资格考试题附答案
- 《静脉血液标本采集指南》试题及答案
- (新版)工业废水处理工理论考试题库(含答案)
- 2025地铁集团考试试题及答案
- (2025年)食源性疾病试题(+答案)
- 2025 年结核宣传培训试题及答案
- (2025年)初级电工证考试题库及参考答案
- (2025年)检验检测机构资质认定(授权签字人)试题(含答案)
- 【训练题】2025年人工智能训练师四级试题及答案试卷+答案
- 天津大学行政岗招录笔试试题2026
- 2026新教材语文 19《航天员写给孩子的信》课件
- 2025-2026学年九年级上学期期中考试化学试题(含答案)
- 尿管护理中的持续质量改进
- 2026中国航天科工集团校招面试常见问答
- 电商物流包装操作指南
- 《桥梁工程试验与检测》课件-地基基础承载力检测-1
- 电力安全警示教育 课件
- 地库环氧底漆施工方案
- CJ/T 409-2012玻璃钢化粪池技术要求
- DB11-T 1191.1-2025 实验室危险化学品安全管理要求 第1部分:工业企业
评论
0/150
提交评论